As of late 2023 and early 2024, there have been ongoing reports of Adderall shortages affecting the United States [1]. These shortages have been attributed to a combination of increased demand and a reduction in the supply of the active pharmaceutical ingredient, amphetamine [1][2].
Why is Adderall difficult to find right now?
The Adderall shortage is primarily linked to production issues by the drug's manufacturers and the U.S. Drug Enforcement Administration's (DEA) control over the amount of amphetamine, a Schedule II controlled substance, that can be manufactured [1][2]. Shire, a subsidiary of Takeda Pharmaceutical Company, which manufactures brand-name Adderall, has experienced production challenges with its key ingredients [1].
How long might the Adderall shortage last?
The duration of the Adderall shortage remains uncertain [3]. While some manufacturers have reported improvements in their supply chain, the overall availability may continue to be affected for some time [2][3].
What happens if I can't get my Adderall prescription filled?
If a pharmacy is out of stock of Adderall, your doctor may suggest alternative stimulant medications such as Ritalin, Concerta, or Vyvanse, or non-stimulant options like Strattera [4]. It is crucial to discuss these alternatives with your healthcare provider, as they can have different effectiveness and side effect profiles [4]. It is also important to avoid taking more than prescribed or sharing medication due to the risks of misuse and addiction [5].
Are there any other brands or generic versions of Adderall available?
Adderall is available in both brand-name and generic forms [6]. Several generic manufacturers produce amphetamine salts, the active ingredient in Adderall [6]. However, the shortage has impacted both brand-name and generic versions [1].
What is the active ingredient in Adderall?
Adderall is a combination of four different amphetamine salts: dextroamphetamine saccharate, dextroamphetamine sulfate, amphetamine aspartate monohydrate, and amphetamine sulfate [7]. This combination works by increasing the levels of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which are thought to play a role in attention and impulse control [7].
Who makes Adderall?
Takeda Pharmaceuticals, through its subsidiary Shire, manufactures brand-name Adderall [1]. Numerous other pharmaceutical companies produce generic versions of amphetamine salts [6].
What are the risks associated with Adderall?
Adderall is a stimulant medication and carries risks, including potential for abuse, dependence, and addiction [5]. Other side effects can include cardiovascular issues, psychiatric problems, and impaired growth in children [5]. It is essential for patients to be monitored by a healthcare professional while taking Adderall [5].
Sources:
[1] https://www.drugpatentwatch.com/blog/adderall-shortage-what-patients-need-to-know
[2] https://www.drugpatentwatch.com/blog/adderall-shortage-what-patients-need-to-know
[3] https://www.drugpatentwatch.com/blog/adderall-shortage-what-patients-need-to-know
[4] https://www.drugpatentwatch.com/blog/adderall-shortage-what-patients-need-to-know
[5] https://www.drugpatentwatch.com/blog/adderall-shortage-what-patients-need-to-know
[6] https://www.drugpatentwatch.com/blog/adderall-shortage-what-patients-need-to-know
[7] https://www.drugpatentwatch.com/blog/adderall-shortage-what-patients-need-to-know